Media Bulletin

Schwartz wins PR accounts for three cancer treatment firms

By Staff

15th September 2010

Category: PR

Following on from its recent signing of melanoma vaccine client, Scancell, Schwartz Communications UK has signed three oncology accounts.

– UK-based Microsulis, which uses microwave technology to destroy previously inoperable tumours

– global health science company MDS Nordion which provides products and services used for the prevention, diagnosis and treatment of disease, specifically liver cancer treatments

– South Korea-based KAEL-GemVax, which is developing new cancer vaccines to enhance survival while maintaining a high quality of life for patients

[lnk|http://www.schwartzcomm.com|_blank|Schwartz Communications UK Limited]

Links for media database subscribers

Not a media database subscriber?

No links attached.

Related news

24th May 2017 PR

Rooster PR chosen by srprs.me

24th May 2017 PR

Michaella Biscomb joins Aberfield Communications

23rd May 2017 PR

The PR Office appointed by SkyX

New! Check out our Media Jobs board for PR and Journalism vacancies Learn more